- Home
- FMST vs CASI Comparison
FMST vs CASI Comparison
Compare FMST & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMST | CASI |
|---|---|---|
| Founded | 2005 | 1991 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 24.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | FMST | CASI |
|---|---|---|
| Price | $3.06 | $0.98 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 247.7K | 29.1K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.55 | $0.93 |
| 52 Week High | $5.74 | $4.05 |
Technical Indicators
Market Signals| Indicator | FMST | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 56.89 | 29.70 |
| Support Level | $2.64 | $0.93 |
| Resistance Level | $3.03 | $1.25 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 99.19 | 11.48 |
Price Performance
Historical ComparisonAbout FMST Foremost Lithium Resource & Technology Ltd. Common stock
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.